Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Nephrology | Urology | Family Medicine
Disease Category: Prostate Cancer
Location: United States, ND

Clinical Trial Details

Overview

Research Study Summary

Prostate Cancer

Purpose

To demonstrate superiority in the overall survival of patients with progressive prostate cancer.

Patient Inclusion Criteria:

  • Confirmed diagnosis of prostate cancer, patients must have surgical or ongoing chemical castration, patients must have disease that has failed one prior docetaxel-based chemotherapy regimen for the treatment of metastatic disease, disease progression

Patient Exclusion Criteria:

  • Prior treatment with sunitinib and more than one prior chemotherapy regimen in the metastatic disease treatment setting, chemotherapy within 3 weeks of the date of the first dose.

To Learn more
Phase

3

Gender

Male

Age

N/A

Overall Status

Recruiting

Facility Type

N/A

Contact

Dr. Tom Davis, Director of Business Development
Legacy Pharma Research
601 N. 5th St.
Bismarck, ND 58501
Phone: 701-751-1128
Fax: 701-751-1131

View Map

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 163092

Date Last Changed: July 24, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.